未登录 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
Stemness-targeted therapies to inhibit cancer cell plasticity in triple negative breast cancer 靶向干细胞特性的疗法以抑制三阴性乳腺癌的癌细胞可塑性 Takchi, A.; Haddad, T.; Zhang, M.; Jalalirad, M.; Suman, V.; Wang, L.; Lange, C.; Ingle, J.; Goetz, M. P.; DAssoro, A. B. 分享 收藏
分享 收藏
Blockade of tumor cell-intrinsic PD-L1 signaling enhances AURKA-targeted therapy in triple negative breast cancer 阻断肿瘤细胞内在PD-L1信号增强三阴性乳腺癌的AURKA靶向治疗 Takchi, Andrew; Zhang, Minzhi; Jalalirad, Mohammad; Ferre, Roberto Leon; Shrestha, Royal; Haddad, Tufia; Sarkaria, Jann; Tuma, Ann; Carter, Jodi; David, Hillman; Giridhar, Karthik; Wang, Liewei; Lange, Carol; Lendahl, Urban; Ingle, James; Goetz, Matthew; D'Assoro, Antonino Bonaventura 分享 收藏
Mechanisms of endocrine resistance to letrozole, fulvestrant, and palbociclib are associated with increased sensitivity to hexyl-cuban-1-yl biguanide inhibitors of CYP3A4 mediated epoxyeicosatrienoic acid biosynthesis Guo, Zhijun; Lei, Jianxun; Makovec, Allison; Jayaraman, Swaathi; Hawse, John R.; Lange, Carol; Ambrose, Elizabeth; Georg, Gunda I.; D'Assoro, Tony; Matthew, Goetz P.; Potter, David A. 分享 收藏
分享 收藏
Glucocorticoid Receptors Drive Breast Cancer Cell Migration and Metabolic Reprogramming via PDK4 Dwyer, Amy R.; Kerkvliet, Carlos Perez; Truong, Thu H.; Hagen, Kyla M.; Krutilina, Raisa, I; Parke, Deanna N.; Oakley, Robert H.; Liddle, Christopher; Cidlowski, John A.; Seagroves, Tiffany N.; Lange, Carol A. 分享 收藏
Receptor for hyaluronan-mediated motility (RHAMM) defines an invasive niche associated with tumor progression and predicts poor outcomes in breast cancer patients 透明质酸介导的运动受体 (RHAMM) 定义了与肿瘤进展相关的侵袭性生态位,并预测乳腺癌患者的不良预后 Tarullo, Sarah E.; He, Yuyu; Daughters, Claire; Knutson, Todd P.; Henzler, Christine M.; Price, Matthew A.; Shanley, Ryan; Witschen, Patrice; Tolg, Cornelia; Kaspar, Rachael E.; Hallstrom, Caroline; Gittsovich, Lyubov; Sulciner, Megan L.; Zhang, Xihong; Forster, Colleen L.; Lange, Carol A.; Shats, Oleg; Desler, Michelle; Cowan, Kenneth H.; Yee, Douglas; Schwertfeger, Kathryn L.; Turley, Eva A.; McCarthy, James B.; Nelson, Andrew C. 分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
分享 收藏
The SMILE Study: A phase II trial of onapristone in combination with fulvestrant for patients with ER-positive and HER2-negative metastatic breast cancer after progression on endocrine therapy and CDK 4/6 inhibitors Kamaraju, Sailaja; Fowler, Amy; Chaudhary, Lubna N.; Burkard, Mark; Giever, Thomas; Hegeman, Robert N.; Pipp-Dahm, Michele; Cheng, Yee Chung; Lange, Carol; Jorns, Julie M.; Stella, Amy; Siddiqui, Nauman; Zurbriggen, Luke; Rajguru, Saurabh; Tarima, Sergey; Sriram, Deepika; Retseck, Janet; Rui, Hallgeir; Sahmoud, Tarek; Wisinski, Kari B. 分享 收藏
Primary results of ONAWA (SOLTI-1802) trial: A window of opportunity trial of onapristone in postmenopausal women with progesterone receptor-positive/HER2-negative early breast cancer (EBC) Bellet, Meritxell; Morales, Serafin; Gasol, Ariadna; Amillano, Kepa; Chic, Nuria; Gonzalez-Farre, Xavier; Villagrasa, Patricia; Pare, Laia; Falato, Claudette; Nuciforo, Paolo; Martinez, Debora; Ferrero-Cafiero, Juan M.; Pascual, Tomas; Prat, Aleix; Lange, Carol; Saura, Cristina 分享 收藏
The SMILE study: A phase 2 trial of onapristone in combination with fulvestrant for patients with ER+ and HER2-metastatic breast cancer after progression on endocrine therapy and CDK4/6 inhibitors Kamaraju, Sailaja; Fowler, Amy; Cheng, Chung Yee; Chaudhary, Lubna N.; Burfeind, John; Retseck, Janet; Tevaarwerk, Amye J.; Burkard, Mark; Paplomata, Elisavet; Parkes, Amanda M.; Jorns, Julie M.; Tarima, Sergey; Yee, Douglas; Rui, Hallgeir; Lange, Carol; Sahmoud, Tarek; Wisinski, Kari B. 分享 收藏